A detailed history of Ubs Asset Management Americas Inc transactions in Xencor Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 332,876 shares of XNCR stock, worth $8.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
332,876
Previous 339,856 2.05%
Holding current value
$8.09 Million
Previous $6.43 Million 4.06%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.7 - $21.65 $109,586 - $151,117
-6,980 Reduced 2.05%
332,876 $6.69 Million
Q2 2024

Aug 13, 2024

BUY
$18.21 - $24.5 $1.28 Million - $1.72 Million
70,163 Added 26.02%
339,856 $6.43 Million
Q1 2024

May 15, 2024

BUY
$18.65 - $26.52 $6,546 - $9,308
351 Added 0.13%
269,693 $5.97 Million
Q4 2023

Feb 14, 2024

SELL
$16.53 - $21.42 $44,812 - $58,069
-2,711 Reduced 1.0%
269,342 $5.72 Million
Q3 2023

Nov 13, 2023

BUY
$20.08 - $25.39 $84,135 - $106,384
4,190 Added 1.56%
272,053 $5.48 Million
Q1 2023

May 15, 2023

BUY
$25.95 - $36.95 $10,302 - $14,669
397 Added 0.15%
267,863 $7.47 Million
Q4 2022

Feb 14, 2023

BUY
$24.79 - $30.86 $430,676 - $536,130
17,373 Added 6.95%
267,466 $6.96 Million
Q3 2022

Nov 14, 2022

BUY
$24.62 - $32.44 $58,201 - $76,688
2,364 Added 0.95%
250,093 $6.5 Million
Q2 2022

Aug 12, 2022

SELL
$19.74 - $29.01 $351,391 - $516,407
-17,801 Reduced 6.7%
247,729 $6.78 Million
Q1 2022

May 16, 2022

SELL
$26.68 - $41.63 $90,738 - $141,583
-3,401 Reduced 1.26%
265,530 $7.08 Million
Q4 2021

Feb 14, 2022

SELL
$33.67 - $43.44 $221,178 - $285,357
-6,569 Reduced 2.38%
268,931 $10.8 Million
Q3 2021

Nov 15, 2021

SELL
$30.65 - $35.68 $192,972 - $224,641
-6,296 Reduced 2.23%
275,500 $9 Million
Q2 2021

Aug 16, 2021

BUY
$34.33 - $44.68 $2.07 Million - $2.7 Million
60,338 Added 27.25%
281,796 $9.72 Million
Q1 2021

May 14, 2021

SELL
$40.81 - $53.88 $111,533 - $147,254
-2,733 Reduced 1.22%
221,458 $9.54 Million
Q4 2020

Mar 01, 2021

SELL
$36.63 - $47.63 $417,362 - $542,696
-11,394 Reduced 4.84%
224,191 $9.78 Million
Q3 2020

Nov 13, 2020

BUY
$30.09 - $43.02 $221,462 - $316,627
7,360 Added 3.22%
235,585 $9.14 Million
Q2 2020

Aug 14, 2020

BUY
$27.76 - $33.42 $343,946 - $414,073
12,390 Added 5.74%
228,225 $7.39 Million
Q1 2020

May 15, 2020

SELL
$20.69 - $37.79 $609,279 - $1.11 Million
-29,448 Reduced 12.01%
215,835 $6.45 Million
Q4 2019

Feb 14, 2020

BUY
$32.75 - $41.43 $64,779 - $81,948
1,978 Added 0.81%
245,283 $8.44 Million
Q3 2019

Nov 14, 2019

BUY
$33.73 - $46.27 $121,056 - $166,063
3,589 Added 1.5%
243,305 $8.21 Million
Q2 2019

Aug 15, 2019

SELL
$29.6 - $40.93 $83,916 - $116,036
-2,835 Reduced 1.17%
239,716 $0
Q1 2019

May 14, 2019

BUY
$27.85 - $38.09 $1.76 Million - $2.4 Million
63,061 Added 35.13%
242,551 $0
Q4 2018

Feb 13, 2019

BUY
$32.39 - $42.05 $4.74 Million - $6.16 Million
146,385 Added 442.18%
179,490 $6.49 Million
Q2 2018

Aug 14, 2018

BUY
$28.41 - $42.41 $191,369 - $285,673
6,736 Added 25.55%
33,105 $0
Q1 2018

May 14, 2018

BUY
$21.18 - $33.78 $360,060 - $574,260
17,000 Added 181.45%
26,369 $0
Q4 2017

Feb 09, 2018

BUY
$19.29 - $24.83 $180,728 - $232,632
9,369
9,369 $0

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.45B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.